This indicates that exosome-mediated transport of miR-19a and miR-614 contributes to airborne allergic rhinosinusitis through the downregulation of RORα and may serve as potential therapeutic targets for treating CRS [29]. This evidence concerns the gene RORA and congenital rubella syndrome.